Marta Vismara
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 09, 2024
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma.
Journal: JCO precision oncology
Published: March 23, 2022
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
Journal: Scientific reports
Published: October 08, 2021
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
Journal: Clinical chemistry
Published: July 21, 2021
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer.
Journal: Cancers
Published: January 29, 2021
Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients.
Journal: Cancers
Published: January 28, 2021
Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.
Journal: Advances in experimental medicine and biology
Published: April 19, 2020
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression.
Journal: International journal of molecular sciences
Published: January 09, 2020
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.
Journal: Seminars in cancer biology
Published: June 14, 2019
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.
Journal: International journal of cancer
Published: May 29, 2019
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
Journal: Oncotarget
Published: February 04, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026